Viewing Study NCT01263951


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-05-07 @ 12:54 AM
Study NCT ID: NCT01263951
Status: UNKNOWN
Last Update Posted: 2021-10-26
First Post: 2010-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
Sponsor: Thomas Jefferson University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Differentiated Thyroid Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Differentiated metastatic thyroid cancer View